Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood and Nerve Supply to the Bones

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Introduction to the inaugural issue of Annals of Palliative Medicine.

Annals of palliative medicine·2015

Same author

Painful boney metastases.

Annals of palliative medicine·2015

Same author

Rapid onset opioids in palliative medicine.

Annals of palliative medicine·2015

Same author

Neuromodulation and palliative medicine.

Annals of palliative medicine·2015

Same author

Painful bone metastases - Can we do better?

Annals of palliative medicine·2015

Same author

Pathophysiology of nausea and vomiting in palliative medicine.

Annals of palliative medicine·2015

Search research articles

Related Experiment Video

Updated: May 30, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Painful osseous metastases.

Howard S Smith¹

¹Albany Medical College, Department of Anesthesiology, 47 New Scotland Avenue, MC-131, Albany, New York 12208, USA. smithh@mail.amc.edu

|July 26, 2011

Summary

This summary is machine-generated.

Cancer patients often suffer severe bone pain from metastases. Understanding tumor-bone interactions can lead to better pain relief and improved quality of life for those with bone metastases.

Related Experiment Videos

Last Updated: May 30, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Area of Science:

Oncology
Pain Management
Skeletal Biology

Background:

Up to 90% of advanced cancer patients experience cancer-related pain, with bone pain affecting at least half.
Bone metastases, particularly from breast, lung, and prostate cancers, impact approximately 400,000 individuals annually in the US.
Osseous metastases lead to reduced quality of life, mobility, independence, and significant refractory pain, posing an economic burden.

Purpose of the Study:

To review current and potential therapeutic strategies for managing pain associated with bone metastases.
To highlight the impact of bone metastases on patient quality of life and the need for effective pain relief.
To emphasize the importance of understanding tumor-bone microenvironment interactions for developing targeted analgesia.

Main Methods:

Literature review of current treatment modalities for painful osseous metastases.
Discussion of the pathophysiology and bi-directional interactions between tumor and bone microenvironment.
Exploration of emerging therapeutic approaches and their potential impact on pain management.

Main Results:

A wide array of treatments exist, including analgesics, radiation, ablative techniques, bisphosphonates, and hormonal therapies.
Despite available treatments, a significant number of patients still suffer from unrelieved pain.
Understanding the mechanisms of bone metastasis development is crucial for advancing targeted analgesic therapies.

Conclusions:

Effective management of painful osseous metastases can improve quality of life, mobility, and reduce skeletal morbidity.
Further research into the pathophysiology of bone metastases promises more selective and effective targeted analgesic therapies.
Future therapeutic approaches hold the potential to revolutionize pain management for bone metastases, optimizing outcomes with minimal adverse effects.